Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this month's Gastroenterology.
Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2- 391 in patients with bone-metastatic, castrate- resistant prostate cancer (CRPC) who have not had prior chemotherapy.
Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men unnecessary surgery, according to a study in the March issue of the American Journal of Roentgenology.
Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men unnecessary surgery, according to a study in the March issue of the American Journal of Roentgenology.
When a federal panel late last year recommended that American women in their 40s need not get annual screening mammograms, Susan G. Komen for the Cure raised concerns that the new guidelines would result in denial of the potentially life- saving procedure for too many young women;
When a federal panel late last year recommended that American women in their 40s need not get annual screening mammograms, Susan G. Komen for the Cure raised concerns that the new guidelines would result in denial of the potentially life- saving procedure for too many young women;
In some states women ages 40 to 49 have less access to mammograms since the U.S. Preventive Services Task Force (USPSTF) released its recommendations to change breast cancer screening guidelines last November, according to a recent survey conducted by the Avon Foundation for Women.
In some states women ages 40 to 49 have less access to mammograms since the U.S. Preventive Services Task Force (USPSTF) released its recommendations to change breast cancer screening guidelines last November, according to a recent survey conducted by the Avon Foundation for Women.
Of the 200,000 men newly diagnosed with prostate cancer each year in the United States, about one- third will undergo surgical treatment. Although open radical prostatectomy (ORP) is regarded as the standard treatment, laparoscopic radical prostatectomy (LRP) with or without robotic assistance is becoming more common.
Of the 200,000 men newly diagnosed with prostate cancer each year in the United States, about one- third will undergo surgical treatment. Although open radical prostatectomy (ORP) is regarded as the standard treatment, laparoscopic radical prostatectomy (LRP) with or without robotic assistance is becoming more common.